Exagen inc. announces study on the long-term effects of covid-19 infection in the development of autoimmune diseases

San diego, march 29, 2021 (globe newswire) -- exagen inc. (nasdaq: xgn), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today that it will collaborate with emory university on a new study about the long-term effects of covid-19 infection in the development of autoimmune diseases. emory is widely acknowledged as a leading research institution in the study of various autoimmune diseases, including lupus.
XGN Ratings Summary
XGN Quant Ranking